These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8456482)

  • 1. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytokine production by cyclosporine A and G.
    McKenna RM; Szturm K; Jeffery JR; Rush DN
    Transplantation; 1989 Feb; 47(2):343-8. PubMed ID: 2493179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.
    Langman LJ; Yatscoff RW
    Ther Drug Monit; 1994 Oct; 16(5):450-7. PubMed ID: 7846742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that cyclosporine G is less deleterious to rat bone in vivo than cyclosporine A.
    Stein B; Takizawa M; Schlosberg M; Movsowitz C; Fallon M; Berlin JA; Epstein S
    Transplantation; 1992 Mar; 53(3):628-32. PubMed ID: 1549857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergism of brequinar sodium and cyclosporine used in combination to prevent cardiac allograft rejection in the rat.
    Cosenza CA; Cramer DV; Eiras-Hreha G; Cajulis E; Wang HK; Makowka L
    Transplantation; 1993 Sep; 56(3):667-72. PubMed ID: 8212165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
    Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
    Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506.
    Saada V; Pham-Huy C; Voisin J; Righenzi S; Rucay P; Claude JR; Duc HT
    Int J Immunopharmacol; 1996 Jan; 18(1):79-87. PubMed ID: 8732436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic and antagonistic effects of combinations of cyclosporine A and its metabolites on inhibition of phytohemagglutinin-induced lymphocyte transformation in vitro.
    Schultz JC; Lensmeyer GL; Wendal TD; Shahidi NT; Wiebe DA; Carlson IH
    Biochem Pharmacol; 1991 Sep; 42(7):1403-10. PubMed ID: 1834063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong additive effect of calcitriol and cyclosporine A on lymphocyte proliferation in vitro and rat liver allotransplantations in vivo.
    Zhang AB; Zheng SS
    Chin Med J (Engl); 2006 Dec; 119(24):2090-5. PubMed ID: 17199961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyslipidemia can reduce the immunosuppressive effects of cyclosporine.
    Pozzetto U; Citterio F; Fioravanti G; Navarra P; Boccalini F; Castagneto M
    Transpl Immunol; 2008 Feb; 18(4):349-51. PubMed ID: 18158122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tepoxalin, a novel immunomodulatory compound, synergizes with CsA in suppression of graft-versus-host reaction and allogeneic skin graft rejection.
    Fung-Leung WP; Pope BL; Chourmouzis E; Panakos JA; Lau CY
    Transplantation; 1995 Aug; 60(4):362-8. PubMed ID: 7652766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
    Sadeg N; Pham-Huy C; Rucay P; Righenzi S; Halle-Pannenko O; Claude JR; Bismuth H; Duc HT
    Immunopharmacol Immunotoxicol; 1993; 15(2-3):163-77. PubMed ID: 8349948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.
    Pilarski LM; Yatscoff RW; Murphy GF; Belch AR
    Leukemia; 1998 Apr; 12(4):505-9. PubMed ID: 9557608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and tolerability of cyclosporine G in human kidney transplant recipients.
    Huser B; Thiel G; Oberholzer M; Beveridge T; Bianchi L; Mihatsch MJ; Landmann J
    Transplantation; 1992 Jul; 54(1):65-9. PubMed ID: 1631947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunopharmacology of immunosuppression by 15-deoxyspergualin.
    Yuh DD; Morris RE
    Transplantation; 1993 Mar; 55(3):578-91. PubMed ID: 7681226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the sensitivity of pig and human peripheral blood mononuclear cells to the antiproliferative effects of traditional and newer immunosuppressive agents.
    Wright DC; Deol HS; Tuch BE
    Transpl Immunol; 1999 Sep; 7(3):141-7. PubMed ID: 10608297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine analogues.
    Jeffery JR
    Clin Biochem; 1991 Feb; 24(1):15-21. PubMed ID: 2060128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunosuppressive activity of the Chinese medicinal plant Tripterygium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine.
    Wang J; Xu R; Jin R; Chen Z; Fidler JM
    Transplantation; 2000 Aug; 70(3):447-55. PubMed ID: 10949186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effects of defibrotide.
    Ferraresso M; Rigotti P; Stepkowski SM; Chou TC; Kahan BD
    Transplantation; 1993 Oct; 56(4):928-33. PubMed ID: 8212219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.